AAP MP Kang meets Gadkari, renews demand for NH status to Sri Anandpur Sahib–Naina Devi Road

The wave of selling from foreign portfolio investors in Indian equities may have reached its end. The resilience of domestic economic fundamentals, accompanied by improving investor sentiment, is promising. With inflows turning positive in June and July, supported by heavy debt investments, foreign investment seems poised for continued strength as India maintains its robust growth.

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy’s, fell up to 2.5% after US President Donald Trump announced a phased tariff plan on imported generic drugs. While generics will remain tariff-free for two years, duties will rise to 100% from August 2028 and 200% from August 2029, weighing on investor sentiment.

Gift Nifty 50 bullish but stretched near 24,800: Live levels